Market revenue in 2023 | USD 110.6 million |
Market revenue in 2030 | USD 144.2 million |
Growth rate | 3.9% (CAGR from 2023 to 2030) |
Largest segment | Serum separating tube |
Fastest growing segment | Coagulation Tubes |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Serum Separating Tube, Plasma Separation Tubes, EDTA Tubes, Rapid Serum Tubes, Coagulation Tubes |
Key market players worldwide | Sekisui Chemical Co Ltd, Becton Dickinson & Co, Cardinal Health Inc, Advin Health Care, AdvaCare Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vacuum blood collection tube market will help companies and investors design strategic landscapes.
Serum separating tube was the largest segment with a revenue share of 29.29% in 2023. Horizon Databook has segmented the China vacuum blood collection tube market based on serum separating tube, plasma separation tubes, edta tubes, rapid serum tubes, coagulation tubes covering the revenue growth of each sub-segment from 2018 to 2030.
In China, several diseases significantly influence the demand for vacuum blood collection tubes. These diseases mainly include diabetes, CVDs, hepatitis, HIV/AIDS, and various types of cancers. According to NIH, in 2022, around 4,824,700 new cancer cases were reported in China, with 2,533,900 in males and 2,290,800 in females.
With increasing cancer rates, the need for blood collection for various tests, including genetic testing, tumor markers, and complete blood counts, is significant. In addition, according to data from the CDC, by 2022, around 1.22 million people were recorded as living with HIV/AIDS in China.
Continued efforts to control HIV/AIDS involve regular blood testing for diagnosis & monitoring of the disease, contributing to the demand for blood collection products. China’s government introduced various initiatives, such as China Comprehensive AIDS Response (China CARES). These factors are expected to support market growth over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the China vacuum blood collection tube market , including forecasts for subscribers. This country databook contains high-level insights into China vacuum blood collection tube market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account